HOMOLOGOUS RECOMBINATION DEFICIENCY
Clinical trials for HOMOLOGOUS RECOMBINATION DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HOMOLOGOUS RECOMBINATION DEFICIENCY trials appear
Sign up with your email to follow new studies for HOMOLOGOUS RECOMBINATION DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race study for prostate cancer drug withdrawn before start
Disease control TerminatedThis study aimed to see if race affects how well a standard prostate cancer drug combination works for men with specific genetic changes in their tumors. It planned to enroll Black, Hispanic, White, and Native American men with advanced prostate cancer that had stopped responding…
Matched conditions: HOMOLOGOUS RECOMBINATION DEFICIENCY
Phase: PHASE2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists hunt for hidden weakness in lung cancer
Knowledge-focused OngoingThis study aims to understand how common a specific DNA repair problem is in people with a certain type of advanced lung cancer (EGFR-mutated NSCLC). Researchers will look at tissue samples from 100 patients to see if having this problem is linked to how patients fare and if it m…
Matched conditions: HOMOLOGOUS RECOMBINATION DEFICIENCY
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC